These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A critical developmental role for tgfbr2 in myogenic cell lineages is revealed in mice expressing SM22-Cre, not SMMHC-Cre. Frutkin AD; Shi H; Otsuka G; Levéen P; Karlsson S; Dichek DA J Mol Cell Cardiol; 2006 Oct; 41(4):724-31. PubMed ID: 16887142 [TBL] [Abstract][Full Text] [Related]
9. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2. Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885 [TBL] [Abstract][Full Text] [Related]
10. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse. Lau J; Minett MS; Zhao J; Dennehy U; Wang F; Wood JN; Bogdanov YD Mol Pain; 2011 Dec; 7():100. PubMed ID: 22188729 [TBL] [Abstract][Full Text] [Related]
11. A vascular smooth muscle-specific integrin-α8 Cre mouse for lymphatic contraction studies that allows male-female comparisons and avoids visceral myopathy. Davis MJ; Kim HJ; Li M; Zawieja SD Front Physiol; 2022; 13():1060146. PubMed ID: 36714313 [No Abstract] [Full Text] [Related]
12. A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo. Yadav D; Conner JA; Wang Y; Saunders TL; Ubogu EE Vascul Pharmacol; 2024 Jun; 155():107369. PubMed ID: 38554988 [TBL] [Abstract][Full Text] [Related]
13. Generation and Comparative Analysis of an Warthi G; Faulkner JL; Doja J; Ghanam AR; Gao P; Yang AC; Slivano OJ; Barris CT; Kress TC; Zawieja SD; Griffin SH; Xie X; Ashworth A; Christie CK; Bryant WB; Kumar A; Davis MJ; Long X; Gan L; Belin de Chantemele EJ; Lyu Q; Miano JM Nat Cardiovasc Res; 2022 Nov; 1(11):1084-1100. PubMed ID: 36424917 [TBL] [Abstract][Full Text] [Related]
14. Generation of a Mouse Model with Smooth Muscle Cell Specific Loss of the Expression of PPARγ. Rautureau Y; Paradis P; Schiffrin EL Methods Mol Biol; 2017; 1527():381-407. PubMed ID: 28116732 [TBL] [Abstract][Full Text] [Related]
15. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity. Undeutsch H; Löf C; Offermanns S; Kero J Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757 [TBL] [Abstract][Full Text] [Related]
16. Development of a smooth muscle-targeted cre recombinase mouse reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation. Regan CP; Manabe I; Owens GK Circ Res; 2000 Sep; 87(5):363-9. PubMed ID: 10969033 [TBL] [Abstract][Full Text] [Related]
17. Identifying the variables that drive tamoxifen-independent CreERT2 recombination: Implications for microglial fate mapping and gene deletions. Van Hove H; Antunes ARP; De Vlaminck K; Scheyltjens I; Van Ginderachter JA; Movahedi K Eur J Immunol; 2020 Mar; 50(3):459-463. PubMed ID: 31785096 [TBL] [Abstract][Full Text] [Related]